View in EDS HTML Full Text PDF Full Text

How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview.

Saved in:
Bibliographic Details
Title: How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview.
Authors: Empeslidis T; Medical Retina Department, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK., Storey M; Medical Retina Department, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK., Giannopoulos T; 1st Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece., Konidaris V; Medical Retina Department, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK., Tranos PG; Ophthalmica Eye Institute, Thessaloniki, Greece., Panagiotou ES; 1st Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece., Voudouragkaki IC; 1st Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece., Konstas AG; 1st and 3rd University Departments of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece. konstas@med.auth.gr.
Source: Advances in therapy [Adv Ther] 2019 Jul; Vol. 36 (7), pp. 1532-1548. Date of Electronic Publication: 2019 May 17.
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Health Communications Inc Country of Publication: United States NLM ID: 8611864 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-8652 (Electronic) Linking ISSN: 0741238X NLM ISO Abbreviation: Adv Ther
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31102206
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Empeslidis+T%22">Empeslidis T</searchLink>; Medical Retina Department, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Storey+M%22">Storey M</searchLink>; Medical Retina Department, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Giannopoulos+T%22">Giannopoulos T</searchLink>; 1st Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Konidaris+V%22">Konidaris V</searchLink>; Medical Retina Department, Leicester Royal Infirmary, University Hospitals of Leicester, Leicester, UK.<br /><searchLink fieldCode="AU" term="%22Tranos+PG%22">Tranos PG</searchLink>; Ophthalmica Eye Institute, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Panagiotou+ES%22">Panagiotou ES</searchLink>; 1st Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Voudouragkaki+IC%22">Voudouragkaki IC</searchLink>; 1st Department of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece.<br /><searchLink fieldCode="AU" term="%22Konstas+AG%22">Konstas AG</searchLink>; 1st and 3rd University Departments of Ophthalmology, Aristotle University of Thessaloniki, Thessaloniki, Greece. konstas@med.auth.gr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%228611864%22">Advances in therapy</searchLink> [Adv Ther] 2019 Jul; Vol. 36 (7), pp. 1532-1548. <i>Date of Electronic Publication: </i>2019 May 17.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Systematic Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Health+Communications+Inc%22">Health Communications Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8611864 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-8652 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%220741238X%22">0741238X </searchLink><i>NLM ISO Abbreviation: </i>Adv Ther
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31102206
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12325-019-00971-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1532
    Titles:
      – TitleFull: How Successful is Switching from Bevacizumab or Ranibizumab to Aflibercept in Age-Related Macular Degeneration? A Systematic Overview.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Empeslidis T
      – PersonEntity:
          Name:
            NameFull: Storey M
      – PersonEntity:
          Name:
            NameFull: Giannopoulos T
      – PersonEntity:
          Name:
            NameFull: Konidaris V
      – PersonEntity:
          Name:
            NameFull: Tranos PG
      – PersonEntity:
          Name:
            NameFull: Panagiotou ES
      – PersonEntity:
          Name:
            NameFull: Voudouragkaki IC
      – PersonEntity:
          Name:
            NameFull: Konstas AG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2019 Jul
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1865-8652
          Numbering:
            – Type: volume
              Value: 36
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Advances in therapy
              Type: main
ResultId 1